Searching journal content for telomerase reverse transcriptase (as phrase) in full text.

Displaying results 1-10 of 46
For checked items
  1. ...telomerase reverse transcriptase ~~~
  2. ...telomerase reverse transcriptase ~~~
  3. ...telomerase reverse transcriptase (hTERT) to maintain telomere 507 ends of DNA(Maida and Masutomi 2015). The ability of hTERT peptides to induce 508 cancer cell-specific cytotoxic T cell activity was explored in the phase III TeloVac 509 study. The MHC class II telomerase vaccine GV1001 was given wit ~~~
  4. ...telomerase reverse transcriptase gene (TERT) p.(Ala279Thr) was the most common DNA sequence variant identified among 435Research J P Dumanski et al. MUTYH substitution Gly396Asp in SI-NETs DOI: 10.1530/ERC-17-0196 © 2017 The authors Printed in Great Britain Publish ~~~
  5. ...telomerase reverse transcriptase ) is also commonly studied in papillary thyroid carcinoma as a prognostic indicator ( Vinagre et al . 2013 , Melo et al . 2014 ). P13K/Akt pathway is activated by either the loss of PTEN expression or a PIK3CA mutation, resulting in downstream β-catenin activation. I ~~~
  6. ...telomerase reverse transcriptase (TERT) and the telomerase RNA complex. At the end of a chromosome, the shelterin complex binds to the telomere and regulates the telomerase activity. It is composed of 6 proteins: telomere repeat-binding factor 1 (TRF1), TRF2, TRF1-interacting nuclear factor 2 (TIN2) ~~~
  7. ...telomerase reverse transcriptase (TERT) and the tumour suppressor TP53 are emerging as feasible tools for molecular prognostication of DTC. In the recent years, mutations of the TERT promoter, with the 1,295,228 C>T (C228T) and the 1,295,250 C>T (C250T) being the most commonly detected, have represe ~~~
  8. ...telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma. Clinical Cancer Research 11 3205–3209. (doi:10.1158/1078-0432.CCR-04-1487) Office for National Statistics 2013 Prostate cancer: the most common cancer among men in England – 2010. London, UK: Office ~~~
  9. ...telomerase reverse transcriptase (TERT) promoter in 71% of melanoma genomes, and these somatic mutations enhanced promoter activity by two- to four-fold (Horn et al. 2013, Huang et al. 2013), which might immortalize proliferative cancer cells by maintaining telomere length (Vinagre et al. 2014). Sta ~~~
  10. ...telomerase reverse transcriptase (Tert) gene, forward, 5′-CTGGCTGATGGACACATACG-3′; reverse, 5′-TGCTCCACACACTCTTACGG-3′. The numbers of positive droplets for the wild-type Pten gene and the control telomerase reverse transcriptase (Tert) gene were read with the QX200 droplet reader. The number of cop ~~~
For checked items